FDA publishes digital health guidances relating to low-risk general wellness products and clinical decision support software.
FDA posts a guidance on Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act.
FDA publishes digital health guidances relating to low-risk general wellness products and clinical decision support software.
FDA posts a guidance on Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act.
FDA releases substantive Warning Letters in the last two weeks of December 2025.
FDA releases the form FDA-483 with three observations from an inspection at the Sun Pharmaceutical Medicare sterile drug manufacturing facility in Halol, Gujarat, India.
